FDA inspection
Merck Sharp & Dohme LLC: FDA inspection ending Jul 15, 2025
FDA inspection 1275520 · No Action Indicated (NAI) · West Point, PA
Key facts
| Inspection ID | 1275520 |
|---|---|
| Firm | Merck Sharp & Dohme LLC |
| FEI number | 2510592 |
| Address | 770 Sumneytown Pike |
| City | West Point |
| State | PA |
| ZIP | 19486 |
| Fiscal year | 2025 |
| Inspection end date | Jul 15, 2025 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring: Human Drugs |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data